secwatch / observer
8-K filed November 8, 2022, 6:59 PM ET ticker OSCR CIK 0001568651
earnings confidence high sentiment neutral materiality 0.80

Oscar Health Q3: Net loss $194M, membership up 81%; CFO transition announced, targets 2024 profitability

Oscar Health, Inc.

2022-Q3 EPS reported -$1.80 revenue$2,968,511,000

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

R. Scott Blackley

Chief Transformation Officer
OSCR · Oscar Health, Inc.
Effective
2022-12-01
Filed
November 8, 2022, 6:59 PM ET
On November 7, 2022, the Board of Directors of the Company (the “Board”) appointed R. Scott Blackley as the Chief Transformation Officer of the Company and Siddhartha Sankaran as Interim Chief Financial Officer of the Company, each effective December 1, 2022 (the “Transition Date”).
Appointed (interim)

Siddhartha Sankaran

Interim Chief Financial Officer
OSCR · Oscar Health, Inc.
Effective
2022-12-01
Filed
November 8, 2022, 6:59 PM ET
On November 7, 2022, the Board of Directors of the Company (the “Board”) appointed R. Scott Blackley as the Chief Transformation Officer of the Company and Siddhartha Sankaran as Interim Chief Financial Officer of the Company, each effective December 1, 2022 (the “Transition Date”).

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Oscar Health, Inc. updated its the third quarter ended September 30, 2022 guidance (reaffirmed).

Period
the third quarter ended September 30, 2022
Guidance
reaffirmed
Result
reported results
Exact text from the filing
On November 8 , 2022, Oscar Health, Inc. (the “Company”), announced the Company’s financial results for the quarter ended September 30, 2022.
View on SEC.gov
Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Oscar Health, Inc. updated its Full Year 2022 guidance (reaffirmed).

Period
Full Year 2022
Guidance
reaffirmed
Result
guidance update
Exact text from the filing
Oscar is updating its FY22 outlook to reflect the impact of higher membership.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

R. Scott Blackley was appointed as Chief Transformation Officer at Oscar Health, Inc..

Action
appointed
Role
Chief Transformation Officer
Exact text from the filing
On November 7, 2022, the Board of Directors of the Company (the “Board”) appointed R. Scott Blackley as the Chief Transformation Officer of the Company and Siddhartha Sankaran as Interim Chief Financial Officer of the Company, each effective December 1, 2022 (the “Transition Date”).
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Siddhartha Sankaran was appointed as Interim Chief Financial Officer at Oscar Health, Inc..

Action
appointed
Role
Interim Chief Financial Officer
Exact text from the filing
On November 7, 2022, the Board of Directors of the Company (the “Board”) appointed R. Scott Blackley as the Chief Transformation Officer of the Company and Siddhartha Sankaran as Interim Chief Financial Officer of the Company, each effective December 1, 2022 (the “Transition Date”).
View on SEC.gov

13 earnings releases filed in the last 30 days. Browse all earnings releases →

Oscar Health, Inc. filing history →

Source: SEC EDGAR
accession 0001568651-22-000054
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.